Con­text Ther­a­peu­tics trims pipeline, cuts down on spend­ing to con­serve cash

To sur­vive the cur­rent mar­ket con­di­tions, Philadel­phia-based Con­text Ther­a­peu­tics has re­sort­ed to cost-cut­ting, a hir­ing freeze and pipeline prun­ing.

The com­pa­ny, which de­vel­ops treat­ments for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER